[1]
2025. The Role of Intralesional Glucantime in Treating Cutaneous Leishmaniasis Lesions Complicated by Secondary Bacterial Infections: Research Article. Pak-Euro Journal of Medical and Life Sciences. 8, 1 (Mar. 2025), 219–226. DOI:https://doi.org/10.31580/pjmls.v8i1.3238.